Literature DB >> 27082636

Comparative proteomic analysis of bronchoalveolar lavage of familial and sporadic cases of idiopathic pulmonary fibrosis.

A Carleo1, E Bargagli, C Landi, D Bennett, L Bianchi, A Gagliardi, C Carnemolla, M G Perari, G Cillis, A Armini, L Bini, P Rottoli.   

Abstract

Idiopathic pulmonary fibrosis (IPF) is a chronic lung disease characterized by progressive deterioration of the alveolar integrity. Among IPF identified phenotypes, that of familial (f-)IPF is usually associated with several gene mutations which are seldom observed in sporadic (s-)IPF. This study aimed at investigating the molecular patterns and variability in f-IPF and s-IPF patients through a differential proteomic analysis. Protein patterns of bronchoalveolar lavage fluid (BALF) samples from 10 familial and 17 sporadic IPF patients were compared using 2D electrophoresis and mass spectrometry. Principal component analysis (PCA) was applied to proteomic data and an enrichment analysis was also performed to characterize specific pathogenic mechanisms and to identify potential biomarkers. BALF samples from f-IPF showed 87 protein spots differentially expressed than those from s-IPF samples; once identified, these spots revealed 22 unique proteins. The functional analysis showed that the endothelial reticulum stress probably plays a central pathogenetic role in f-IPF with an up-regulation of proteins involved in wounding and immune responses, coagulation system, and ion homeostasis. Up-regulated proteins in the s-IPF group were those involved in the oxidative stress response. PCA analysis of differentially expressed proteins clearly distinguished f-IPF from s-IPF patients, and in agreement with radiological and histological patterns, pointed out a higher heterogeneity in f-IPF than s-IPF samples. The 'Slit/Robo signaling', 'clathrin-coated vesicle' and 'cytoskeleton remodelling', were extrapolated by 'pathways analysis' and the results of 'diseases (by biomarkers)' highlighted a 'connective tissue and autoimmune disease', two aspects of increasing interest in IPF.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27082636     DOI: 10.1088/1752-7155/10/2/026007

Source DB:  PubMed          Journal:  J Breath Res        ISSN: 1752-7155            Impact factor:   3.262


  10 in total

Review 1.  Oxidant/Antioxidant Disequilibrium in Idiopathic Pulmonary Fibrosis Pathogenesis.

Authors:  Paolo Cameli; Alfonso Carleo; Laura Bergantini; Claudia Landi; Antje Prasse; Elena Bargagli
Journal:  Inflammation       Date:  2020-02       Impact factor: 4.092

Review 2.  Decrypting the crosstalk of noncoding RNAs in the progression of IPF.

Authors:  Yujuan Wang; Han Xiao; Fenglian Zhao; Han Li; Rong Gao; Bingdi Yan; Jin Ren; Junling Yang
Journal:  Mol Biol Rep       Date:  2020-03-16       Impact factor: 2.316

3.  New Strategies and Challenges in Lung Proteomics and Metabolomics. An Official American Thoracic Society Workshop Report.

Authors:  Russell P Bowler; Chris H Wendt; Michael B Fessler; Matthew W Foster; Rachel S Kelly; Jessica Lasky-Su; Angela J Rogers; Kathleen A Stringer; Brent W Winston
Journal:  Ann Am Thorac Soc       Date:  2017-12

Review 4.  HSP90 Inhibition and Modulation of the Proteome: Therapeutical Implications for Idiopathic Pulmonary Fibrosis (IPF).

Authors:  Ruben Manuel Luciano Colunga Biancatelli; Pavel Solopov; Betsy Gregory; John D Catravas
Journal:  Int J Mol Sci       Date:  2020-07-25       Impact factor: 5.923

5.  Small molecule proteomics quantifies differences between normal and fibrotic pulmonary extracellular matrices.

Authors:  Xin-Long Wan; Zhi-Liang Zhou; Peng Wang; Xiao-Ming Zhou; Meng-Ying Xie; Jin Mei; Jie Weng; Hai-Tao Xi; Chan Chen; Zhi-Yi Wang; Zhi-Bin Wang
Journal:  Chin Med J (Engl)       Date:  2020-05-20       Impact factor: 2.628

6.  Label-free plasma proteomics identifies haptoglobin-related protein as candidate marker of idiopathic pulmonary fibrosis and dysregulation of complement and oxidative pathways.

Authors:  Mayank Saraswat; Sakari Joenväärä; Tiialotta Tohmola; Eva Sutinen; Ville Vartiainen; Katri Koli; Marjukka Myllärniemi; Risto Renkonen
Journal:  Sci Rep       Date:  2020-05-08       Impact factor: 4.379

7.  Proteome Characterization of BALF Extracellular Vesicles in Idiopathic Pulmonary Fibrosis: Unveiling Undercover Molecular Pathways.

Authors:  Enxhi Shaba; Claudia Landi; Alfonso Carleo; Lorenza Vantaggiato; Eugenio Paccagnini; Mariangela Gentile; Laura Bianchi; Pietro Lupetti; Elena Bargagli; Antje Prasse; Luca Bini
Journal:  Int J Mol Sci       Date:  2021-05-27       Impact factor: 5.923

Review 8.  Evaluation of oxidative stress biomarkers in idiopathic pulmonary fibrosis and therapeutic applications: a systematic review.

Authors:  Alessandro G Fois; Panagiotis Paliogiannis; Salvatore Sotgia; Arduino A Mangoni; Elisabetta Zinellu; Pietro Pirina; Ciriaco Carru; Angelo Zinellu
Journal:  Respir Res       Date:  2018-03-27

Review 9.  Metabolic Dysregulation in Idiopathic Pulmonary Fibrosis.

Authors:  Elena Bargagli; Rosa Metella Refini; Miriana d'Alessandro; Laura Bergantini; Paolo Cameli; Lorenza Vantaggiato; Luca Bini; Claudia Landi
Journal:  Int J Mol Sci       Date:  2020-08-07       Impact factor: 5.923

Review 10.  Role of extracellular vesicles in chronic lung disease.

Authors:  Anne Trappe; Seamas C Donnelly; Paul McNally; Judith A Coppinger
Journal:  Thorax       Date:  2021-03-12       Impact factor: 9.139

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.